Torrent Pharma shares rise 6% to 52-week high after Q3 results
pre-market1 source ↓written by the desknot a recommendation
- Pharmaceuticals reported
- 17.6% YoY revenue increase
- for Q3 FY26
- ₹3,303 cr
- ₹635 cr
- shares surged
- 6.05%
- 52-week high
Torrent Pharmaceuticals reported a 17.6% YoY revenue increase to ₹3,303 cr for Q3 FY26, with net profit up 26.2% to ₹635 cr. Following these results, shares surged 6.05% to a 52-week high of ₹4,324.90 on the NSE. This strong performance reflects robust demand and effective cost management.
Not investment advice. For informational purposes only.